Literature DB >> 3840396

Experimental testing of Mackay's model for functional antagonism in the isolated costo-uterus of the rat.

P J Henry, K M Lulich, J W Paterson.   

Abstract

Several key predictions of a recently developed model for functional antagonism (Mackay, 1981) were experimentally tested using the rat isolated costo-uterine preparation. In the presence of the functional antagonist fenoterol (Fen), the functional constants (KAF) for carbachol and oxotremorine (Oxo) were respectively 9.9 and 3.4 fold greater than their corresponding affinity constants (KA). According to Mackay's model for functional antagonism, the higher KAF/KA ratio for carbachol indicates that this cholinoceptor agonist has a greater efficacy than Oxo. This was confirmed by using conventional pharmacological methods. As predicted from the model of functional antagonism, the plot of KAF/KA-1 against the fraction of cholinoceptors not irreversibly blocked by phenoxybenzamine (Pbz) was linear for both carbachol and Oxo and the lines of best fit crossed the axes at a point not significantly different from the origin. The value of 4.6 for the relative efficacy of carbachol to Oxo estimated from functional antagonism studies was comparable to the value of 5.6 calculated using the method of irreversible antagonism proposed by Furchgott (1966).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3840396      PMCID: PMC1916845          DOI: 10.1111/j.1476-5381.1985.tb09443.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

Review 1.  Pharmacological characterization of receptors: its relation to radioligand-binding studies.

Authors:  R F Furchgott
Journal:  Fed Proc       Date:  1978-02

2.  Sensitization of contracted tracheal smooth muscle to beta-adrenergic spasmolysis by subthreshold doses of papaverine.

Authors:  F G van den Brink; J Offermeier; H J Griessel
Journal:  Scand J Respir Dis Suppl       Date:  1977

3.  Analysis of dose-response curves and calculation of agonist dissociation constants using a weighted nonlinear curve fitting program.

Authors:  G A McPherson; P Molenaar; C Raper; E Malta
Journal:  J Pharmacol Methods       Date:  1983-12

4.  Experimental evidence and dynamic aspects of spare receptor.

Authors:  K Takeyasu; S Uchida; A Wada; M Maruno; R T Lai; F Hata; H Yoshida
Journal:  Life Sci       Date:  1979-11-12       Impact factor: 5.037

5.  Determination of dissociation constants and relative efficacies of oxotremorine analogs at muscarinic receptors in the guinea-pig ileum by pharmacological procedures.

Authors:  B Ringdahl
Journal:  J Pharmacol Exp Ther       Date:  1984-04       Impact factor: 4.030

6.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

7.  A theoretical model for the use of functional antagonism to estimate dissociation constants for agonists.

Authors:  G L Amidon; C K Buckner
Journal:  J Pharmacol Methods       Date:  1982-03

8.  The model of functional interaction. I. Development and first check of a new model of functional synergism and antagonism.

Authors:  F G van den Brink
Journal:  Eur J Pharmacol       Date:  1973-06       Impact factor: 4.432

9.  An analysis of functional antagonism and synergism.

Authors:  D Mackay
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

10.  A test of the null equation for functional antagonism.

Authors:  J Emmerson; D Mackay
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

View more
  2 in total

1.  Interactions between responses mediated by activation of adenosine A2 receptors and alpha 1-adrenoceptors in the rabbit isolated aorta.

Authors:  H L Wiener; G P Thalody; S Maayani
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

2.  Gender and tachycardia: independent modulation of platelet reactivity in patients with atrial fibrillation.

Authors:  Nathan Ek Procter; Jocasta Ball; Doan Tm Ngo; Jeffrey S Isenberg; Elaine M Hylek; Yuliy Y Chirkov; Simon Stewart; John D Horowitz
Journal:  J Geriatr Cardiol       Date:  2016-03       Impact factor: 3.327

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.